What if the test meant to reassure you… could actually miss cancer?
Bleeding after menopause is often the first—and sometimes only—warning sign of uterine cancer, yet new evidence shows the way we’ve been evaluating it may not be enough. In this must-listen episode, Dr. Stephanie Hack, MD, MPH breaks down the latest ACOG guidelines that are reshaping care, explaining why ultrasound alone can miss serious disease and what should happen instead.
If you’ve ever been told “everything looks normal,” or you care about a woman who has—this episode could change what happens next.
- ACOG Clinical Practice Update (2026): Updated Guidance Regarding the Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Individuals With Postmenopausal Bleeding
- American Cancer Society: Endometrial Cancer Statistics
- https://www.cancer.org/cancer/types/endometrial-cancer/about/key-statistics.html
- AACR (American Association for Cancer Research): Uterine Cancer Projections
- https://www.aacr.org/about-the-aacr/newsroom/news-releases/u-s-uterine-cancer-incidence-and-mortality-rates-expected-to-significantly-increase-by-2050/
- NCBI/StatPearls: Endometrial Cancer Overview
- https://www.ncbi.nlm.nih.gov/books/NBK525981/
No transcript available.
POWERED BY BLUBRRY
